KNSA
Kiniksa Pharmaceuticals International Plc
NASDAQ · Healthcare · Biotechnology · BM
$77.24
−2.63%Forward multiples
Based on analyst estimates
- P/E forward
- 48.66x
- P/E 2026E
- 56.16x
- P/E 2027E
- 38.13x
- P/E 2028E
- 28.20x
- P/S forward
- 5.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- 72.19x
- PEG TTM
- 1.51x
- Price / book
- 9.21x
- Price / sales
- 7.17x
- Price / cash flow
- 32.54x
Enterprise value
- Enterprise value
- $5.5B
- EV / sales
- 6.55x
- EV / EBITDA
- 49.15x
- EV / EBIT
- 54.96x
- Market cap
- $6.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026